Validation and update of a prediction model for risk of relapse after cessation of anti-TNF treatment in Crohn's disease.

Autor: Ten Bokkel Huinink S; Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam., de Jong DC; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam., Nieboer D; Department of Public Health, Erasmus Medical Center, Rotterdam., Thomassen D; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden., Steyerberg EW; Department of Public Health, Erasmus Medical Center, Rotterdam.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden., Dijkgraaf MGW; Department of Epidemiology and Data Science, Amsterdam UMC, University of Amsterdam, Amsterdam., Bodelier AGL; Department of Gastroenterology and Hepatology, Amphia Hospital, Breda., West RL; Department of Gastroenterology and Hepatology, Franciscus Gasthuis & Vlietland, Rotterdam., Römkens TEH; Department of Gastroenterology and Hepatology, Jeroen Bosch Hospital, Den Bosch., Hoentjen F; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen., Mallant RC; Department of Gastroenterology and Hepatology, Flevo Hospital, Almere., van Tuyl BAC; Department of Gastroenterology and Hepatology, Diakonessenhuis Utrecht, Utrecht., Mares WGN; Department of Gastroenterology and Hepatology, Gelderse Vallei Hospital, Ede., Wolfhagen FHJ; Department of Gastroenterology and Hepatology, Albert Schweitzer Hospital, Dordrecht., Dijkstra G; Department of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen., Reijnders JGP; Department of Gastroenterology and Hepatology, Haga Hospital, Den Haag., de Boer NK; Department of Gastroenterology and Hepatology, AG&M Research Institute, Amsterdam University Medical Centre, Vrije Universiteit Amsterdam, Amsterdam., Tan ACITL; Department of Gastroenterology and Hepatology, Canisius Wilhelmina Hospital, Nijmegen., van Boeckel PGA; Department of Gastroenterology and Hepatology, St. Antonius Hospital, Nieuwegein., Tack GJ; Department of Gastroenterology and Hepatology, Medical Centre Leeuwarden, Leeuwarden., van Asseldonk DP; Department of Gastroenterology and Hepatology, NWZ Alkmaar, Alkmaar, The Netherlands., D'Haens GRAM; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam., van der Woude CJ; Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam., Duijvestein M; Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam.; Department of Gastroenterology and Hepatology, AG&M Research Institute, Amsterdam University Medical Centre, Vrije Universiteit Amsterdam, Amsterdam., de Vries AC; Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam.

Publikováno v: European journal of gastroenterology & hepatology [Eur J Gastroenterol Hepatol] 2022 Oct 01; Vol. 34 (10), pp. 983-992. Date of Electronic Publication: 2022 Aug 30.

A prospective cohort study of renal function and bone turnover in adults with hepatitis B virus (HBV)‐HIV co‐infection with high prevalence of tenofovir‐based antiretroviral therapy use.

Autor: Gizaw, Andinet¹, King, Wendy C.², Hinerman, Amanda S.², Chung, Raymond T.³, Lisker‐Melman, Mauricio⁴, Ghany, Marc G.⁵, Khalili, Mandana⁶, Jain, Mamta K.⁷, Graham, Jacob⁸, Swift‐Scanlan, Theresa⁸, Kleiner, David E.⁹, Sulkowski, Mark¹⁰, Wong, David K.¹¹, Sterling, Richard K.¹ richard.sterling@vcuhealth.org

Publikováno v: HIV Medicine. Jan2023, Vol. 24 Issue 1, p55-74. 20p.

Hepatitis B e antigen and e antibody in a multi-ethnic cohort of adult chronic hepatitis B virus patients followed at a single liver unit for a period of 20 years.

Autor: Mutimer, David^1,2 david.mutimer@uhb.nhs.uk, Elsharkawy, Ahmed¹, Hathorn, Emma¹, Arunkumar, Selvi³

Publikováno v: Journal of Viral Hepatitis. Oct2022, Vol. 29 Issue 10, p879-889. 11p.

Maintained virological suppression and renal function with reduced dose tenofovir disoproxil fumarate in renally impaired chronic hepatitis B patients.

Autor: Liem, Kin Seng^1,2 (AUTHOR), Wong, David K.¹ (AUTHOR), Fung, Scott¹ (AUTHOR), Zahirieh, Alireza³ (AUTHOR), Yim, Colina¹ (AUTHOR), Zanjir, Wayel R.¹ (AUTHOR), Feld, Jordan J.^1,4 (AUTHOR), Hansen, Bettina E.^1,5 (AUTHOR), Janssen, Harry L. A.¹ (AUTHOR) harry.janssen@uhn.ca

Publikováno v: Journal of Viral Hepatitis. Jan2021, Vol. 28 Issue 1, p51-60. 10p.

Decreased All-Cause and Liver-Related Mortality Risk in HIV/Hepatitis B Virus Coinfection Coinciding With the Introduction of Tenofovir-Containing Combination Antiretroviral Therapy.

Autor: Welzen, Berend J van¹ (AUTHOR) b.j.vanwelzen@umcutrecht.nl, Smit, Colette² (AUTHOR), Boyd, Anders^2,3 (AUTHOR), Lieveld, Faydra I¹ (AUTHOR), Mudrikova, Tania¹ (AUTHOR), Reiss, Peter^2,4 (AUTHOR), Brouwer, Annemarie E⁵ (AUTHOR), Hoepelman, Andy I M¹ (AUTHOR), Arends, Joop E¹ (AUTHOR)

Publikováno v: Open Forum Infectious Diseases. Jul2020, Vol. 7 Issue 7, p1-9. 9p.